For the Inventor, By the Inventor

Enter assignee name

Westminster, CO, United States of America

Arca Biopharma, Inc.

USPTO Granted Patents = 14

CIPO Patents = 7

EPO Patents = 3

Trademarks = 3

Forward Citations = 67

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Michael R Bristow (6 out of 19 patents)

Arie Abo (5 out of 13 patents)

Jonathan D Port (4 out of 4 patents)

4. Wouter Korver (4 out of 7 patents)

5. Christopher Dufton (2 out of 3 patents)

6. Walter D Funk (2 out of 21 patents)

7. Y Tom Tang (2 out of 92 patents)

8. Bryan J Boyle (2 out of 10 patents)

9. Radoje Drmanac (1 out of 131 patents)

10. Makoto Kakitani (1 out of 4 patents)

11. Kazuma Tomizuka (1 out of 29 patents)

12. Takeshi Oshima (1 out of 2 patents)

13. Minke Binners (1 out of 1 patent)

14. Chiaoyun Kuo (1 out of 2 patents)

15. Jian Rui Wang (1 out of 2 patents)

14 patents: Sort by Forward Citations

1. 11554107 - Methods and compositions involving bucindolol for the treatment of atrial fibrillation (2023-01-17),

2. 11452712 - Methods and compositions involving (S)-bucindolol (2022-09-27),

3. 10925856 - Methods and compositions involving bucindolol for the treatment of atrial fibrillation (2021-02-23),

4. 9763916 - Methods and compositions involving (S)-bucindolol (2017-09-19),

5. 9446023 - Methods and compositions involving (S)-bucindolol (2016-09-20),

6. 8993726 - Antibodies to NTB-A (2015-03-31),

7. 8946284 - Methods and compositions involving (S)-bucindolol (2015-02-03),

8. 8715941 - Antibodies to LRP6 (2014-05-06),

9. 8536310 - Antibodies to CLL-1 (2013-09-17),

10. 8193320 - Antibodies to NTB-A (2012-06-05),

11. 7981413 - Methods and compositions concerning antibodies that bind CD84-like polypeptides (2011-07-19),

12. 7951381 - Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factor (2011-05-31),

13. 7847067 - Antibodies to NTB-A (2010-12-07),

14. 7674890 - Stem cell factor-like proteins and uses thereof (2010-03-09),

Arca Biopharma, Inc. is a biopharmaceutical company focused on developing genetically-targeted therapies for cardiovascular diseases. Their mission is to identify, develop, and commercialize innovative treatments that improve patients' lives. With a strong commitment to precision medicine, Arca Biopharma utilizes biomarker information to select and personalize their drug candidates. Through extensive research and collaborations, they aim to address unmet medical needs and make a significant impact in the field of cardiovascular medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

14 Patents

#10 in Westminster, CO

#428 in Colorado

#21,598 in US

#40,882 in the World

Westminster, CO, United States of America

Arca Biopharma, Inc.

Forward Citations = 67

21 inventors:

Michael R Bristow (6 out of 19 patents)

Arie Abo (5 out of 13 patents)

Jonathan D Port (4 out of 4 patents)

4. Wouter Korver (4 out of 7 patents)

5. Christopher Dufton (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…